Plenary Session - inactive due to federal service
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail [email protected].
- Update frequency
- every 6 days
- Average duration
- 64 minutes
- Episodes
- 397
- Years Active
- 2018 - 2025
4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour
Today we're joined by social epidemiologist, Dr. Maria Glymour of UCSF. We talk about her work in studying public health interventions for dementia and how her experience in academia has led to her c…
01:18:23 |
Wed 01 Sep 2021
4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin
We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting…
00:59:01 |
Fri 27 Aug 2021
4.16 Treating Lymphoma, Histiocytic Disorders, Learning by Teaching, & More! with Dr. Bita Fakhri
Today we interview Dr. Bita Fakhri of UCSF on the current research behind treatments for lymphoma. We touch on CAR-T, ABVD, DA-EPOCH-R, and more. We also talk about histiocytic disorders, Dr. Fakhri'…
01:05:00 |
Sat 21 Aug 2021
4.15 #AllCOVID-19: the Tough Questions About Policies Concerning the Delta Variant of COVID-19
Today we're compiling all our recent monologues on COVID-19. That's right -- we're taking a break from #zerocovid to give you an episode that's #allcovid! We cover a whole range of news and opinions …
00:42:16 |
Thu 19 Aug 2021
4.14 Evolution of GI Cancer Therapy, Editing JCO, Advice for Clinical Trialists with Dr. Alan Venook
Today we interview Dr. Alan Venook of UCSF, a renowned expert in clinical trial design and gastrointestinal malignancies. We talk about the evolution of the treatment for colorectal cancer over the l…
01:08:23 |
Wed 11 Aug 2021
4.13 Lessons from Publishing 300 Peer-Reviewed Papers & What Telemedicine Will Do to Cancer Care
We have two short thinkpieces for you. The first is on the lessons that can be learned, or have been learned along the way, from publishing 300 peer-reviewed papers in medical/scientific journals. Th…
00:14:51 |
Fri 06 Aug 2021
4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier
Today we interview Dr. Josee-Lyne Ethier of Queen's University in Kingston, Ontario, Canada on her new paper "Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positi…
00:35:50 |
Tue 03 Aug 2021
4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain
Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARA…
00:54:18 |
Sat 31 Jul 2021
4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial…
00:58:58 |
Wed 28 Jul 2021
4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma
Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with l…
00:26:38 |
Fri 23 Jul 2021
4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021
In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval…
00:11:31 |
Fri 16 Jul 2021
4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad
We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialt…
00:49:01 |
Fri 09 Jul 2021
4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee
We sat down in person with Dr. Rahul Banerjee, a BMT/CAR-T fellow at UCSF, to talk about all manner of topics including CAR-T, randomized trials in oncology (and, specifically, Dr. Banerjee's two rec…
01:31:43 |
Thu 08 Jul 2021
4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evide…
00:53:16 |
Wed 07 Jul 2021
4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs
Today we have a short monologue for you on just a few topics: a treatment algorithm for follicular lymphoma and our host Dr. Prasad's new paper out now in the European Journal of Clinical Investigati…
00:30:34 |
Sat 26 Jun 2021
4.03 Multiple Myeloma, Productivity Metrics, and Field Changes in Oncology with Dr. Nina Shah
Today we're back with another real-life (non-virtual!) interview. We're joined by Dr. Nina Shah of UCSF to discuss her career and her work in mutiple myeloma as well as the complexities of advancing …
01:09:26 |
Fri 18 Jun 2021
4.02 The History of Breast Cancer Research and Treatment with Dr. George Sledge
Today we sit down with Dr. George Sledge of the Stanford University Medical Center to hear the story of his career and to discuss the history of breast cancer research and treatment.
Back us on Patr…
01:43:36 |
Tue 15 Jun 2021
4.01 Highlights from the 2021 ASCO Annual Meeting
Today we're launching season 4 of Plenary Session! This season we're returning to our love of monologues. On today's episode we talk about highlights from the recent annual meeting of the American So…
00:49:58 |
Fri 11 Jun 2021
3.90 Redesigning Health Care, Overuse, Burnout, and COVID-19 Groupthink with Dr. Marty Makary
On today's episode, we interview Dr. Marty Makary of Johns Hopkins School of Medicine and Bloomberg School of Public Health on how he chose his path in medicine, how health care as it is in the Unite…
01:16:02 |
Fri 04 Jun 2021
3.89 How to Think About COVID-19 Policy with Rare Events and Declining Probabilities
Today we have a brief monologue for you on how to think about COVID-19 policy in the context of rare event and declining probabilities. We also touch on what to expect from season 4 of this podcast, …
00:27:57 |
Thu 03 Jun 2021
Disclaimer: The podcast and artwork embedded on this page are the property of Vinay Prasad, MD MPH ([email protected]). This content is not affiliated with or endorsed by eachpod.com.